David Gaugh

Interim President & CEO
David Gaugh

David Gaugh has over 30 years of leadership experience in the Healthcare and Pharmaceutical business. He has been employed by AAM (formerly GPhA) since February 2012 as the Executive Vice President for Sciences and Regulatory Affairs, where he has responsibility for the professional liaison functions between member companies, agencies of the U.S. Government and Legislative bodies for all responsible areas. In December 2022 David was named Interim President & CEO of AAM.

Prior to joining AAM, David was Vice President and General Manager of Bedford Laboratories, a wholly owned subsidiary of Boehringer Ingelheim. Prior to Bedford Laboratories, David was Senior Director, Pharmacy Contracting and Marketing at VHA/Novation (now Vizient). And prior to VHA/Novation, David was System Director of Pharmacy for St. Luke’s Health-System, a tertiary-care hospital in Kansas City, MO. David is a registered Pharmacist and has been engaged in several board-level pharmacy-related activities.

Latest Tweets

Association for Accessible Medicines


Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.